e-learning
resources
Vienna 2009
Monday, 14.09.2009
Assessment of severity in respiratory infections: severity scales and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of older age on biomarker concentrations in patients with community acquired pneumonia
S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Henningsdorf, Ulm, Berlin, Hannover, Germany)
Source:
Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Session:
Assessment of severity in respiratory infections: severity scales and biomarkers
Session type:
Thematic Poster Session
Number:
2363
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Henningsdorf, Ulm, Berlin, Hannover, Germany). Influence of older age on biomarker concentrations in patients with community acquired pneumonia. Eur Respir J 2009; 34: Suppl. 53, 2363
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinical characteristics and symptoms in older and younger patients with community acquired pneumonia
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs
Source: Eur Respir J 2001; 17: 200-205
Year: 2001
Significance of comorbidity in elderly patients with community acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 3s
Year: 2006
Clinical presentation and evolution of community acquired pneumonia in older patients
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Influence of medical comorbidities in patients with community acquired pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
The general evaluation of elderly patients with community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004
The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007
The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
Influence of age in the clinical differentiation of atypical pneumonia in adults
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Excess age dependent short- and long-term mortality in patients with community acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease
Source: Eur Respir J 2002; 20: Suppl. 38, 283s
Year: 2002
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
Severity assessment in adults patients aged <50 years admitted with community acquired pneumonia
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Impact of age in the clinical expression of COPD in Greek patients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
The most frequent bacterial causes of pneumonia in children over 3 yrs of age - some characteristics
Source: Eur Respir J 2002; 20: Suppl. 38, 191s
Year: 2002
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept